未知生产厂商
EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.
EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.
EHC18 is an oral compound thought to modulate immune responses to HCV by inducing tolerance, or non-responsiveness to viral antigens, thus potentially reducing inflammation.
Investigated for use/treatment in hepatitis (viral, C) and hepatocellular carcinoma.
